حليمة بي. ساريبادا ، الكاتبة المساهمة في Haleema P. Saripada

Top Stories
Gokce Bilgin, MD, presented results of a Pluvicto study June 21 at SNMMI 2025 in New Orleans.
Molecular Imaging
SNMMI: Retreatment with Lu-177 PSMA-617 shows promise in mCRPC patients
Retreatment with Lu-177 PSMA-617 is emerging as a potential approach in men with prostate cancer.
New H3 Tracers Thumbnail
Nuclear Medicine
SNMMI: New PET tracers developed for imaging brain disorders
Top image displays a patient assessed for acute renal failure following third Lutathera administration where 3D dosimetry showed an average-per-administration kidney absorbed dose of 5 Gray, with total course of therapy being well under toxicity limits. Bottom image displays a patient’s absorbed dose to the colon after his first dose of Pluvicto where 3D dosimetry was used to confirm transient bowel obstruction leading to treatment management.
Molecular Imaging
SNMMI: SPECT/CT valuable after Lu-177 therapy
2025 06 20 Academicrad Bacs Deep Learning Thumbnail
Womens Imaging
DL model improves detection of breast arterial calcifications
Join Us June 26 at 12 Noon ET for a FREE webinar!
Sponsor Content
Join Us June 26 at 12 Noon ET for a FREE webinar!
More in Home
SNMMI: Retreatment with Lu-177 PSMA-617 shows promise in mCRPC patients
By Will Morton
Retreatment with Lu-177 PSMA-617 is emerging as a potential approach in men with prostate cancer.
June 21, 2025
Gokce Bilgin, MD, presented results of a Pluvicto study June 21 at SNMMI 2025 in New Orleans.
SNMMI: New PET tracers developed for imaging brain disorders
By Will Morton
Two newly developed PET imaging agents are effective for identifying a highly expressed receptor in neurological and psychiatric conditions.
June 21, 2025
New H3 Tracers Thumbnail
SNMMI: SPECT/CT valuable after Lu-177 therapy
By Will Morton
Post-therapy SPECT/CT imaging can optimize treatment outcomes and protected patients undergoing radiopharmaceutical therapy.
June 21, 2025
Top image displays a patient assessed for acute renal failure following third Lutathera administration where 3D dosimetry showed an average-per-administration kidney absorbed dose of 5 Gray, with total course of therapy being well under toxicity limits. Bottom image displays a patient’s absorbed dose to the colon after his first dose of Pluvicto where 3D dosimetry was used to confirm transient bowel obstruction leading to treatment management.
DL model improves detection of breast arterial calcifications
By Amerigo Allegretto
Researchers have developed a deep-learning (DL) model that can find and characterize breast arterial calcifications on mammograms.
June 20, 2025
2025 06 20 Academicrad Bacs Deep Learning Thumbnail
Brain MRI helps predict outcomes in cardiac arrest survivors
By Kate Madden Yee
Quantitative brain MRI data appear to help clinicians forecast the effects of out-of-hospital cardiac arrest among those who survive it.
June 20, 2025
Heart Damage
Could radiation therapy for breast cancer lower Alzheimer's risk?
By Amerigo Allegretto
Radiation therapy for breast cancer treatment may lead to a lower risk of developing Alzheimer's disease in survivors.
June 20, 2025
Woman Anxious Thumbnail
Removing patient fees for DBT improves utilization, but inequity remains
By Erik L. Ridley
In a recent study, eliminating out-of-pocket costs for DBT reduced, but did not eliminate, disparities in utilization.
June 19, 2025
Medical Bill Final Notice
PET/CT metric improves staging of patients with lung cancer
By Will Morton
A group in Korea suggests adding maximum standardized uptake values into initial lung cancer staging guidelines.
June 19, 2025
Lung Cancer
3 ways to manage effects of medical malpractice stress syndrome
By Kate Madden Yee
Medical malpractice stress syndrome can cause significant emotional, behavioral, and physical symptoms.
June 19, 2025
Doctor Technologist Burnout
Mammography screening leads to better cancer outcomes
By Amerigo Allegretto
Breast cancers found via screening mammography are linked to smaller tumor size, less-invasive therapies, and improved survival.
June 19, 2025
Mammo Reading 400
Virtual training improves cardiopulmonary POCUS use
By Amerigo Allegretto
Virtual training can help nonexperts better use cardiopulmonary point-of-care ultrasound (POCUS) in remote areas.
June 18, 2025
ARCTICA program hub-and-spoke model and timeline. Image available for republishing under Creative Commons license (CC BY-NC-ND 4.0).
MRI bests pathology for presurgical measurement of breast tumors
By Kate Madden Yee
MRI demonstrated the highest concordance with tumor size and T stage.
June 18, 2025
Breast Cancer
Page 1 of 146
Next Page